CHAINBRIDGE MEDICAL PARTNERSHIP
SHIBDON ROAD, BLAYDON-ON-TYNE
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 194 | 241 | 80.5% | |
| CKD 4 | 2008 | 233 | 287 | 81.2% | |
| CKD 5 | 2009 | 95 | 114 | 83.3% | |
| CKD 5 | 2010 | 20 | 21 | 95.2% | |
| CKD 5 | 2011 | 21 | 23 | 91.3% | |
| CKD 5 | 2012 | 24 | 29 | 82.8% | |
| CKD 5 | 2013 | 22 | 26 | 84.6% | |
| CKD003 | 2014 | 13 | 14 | 92.9% | |
| CKD003 | 2015 | 22 | 23 | 95.7% | |
| NM84 | 2016 | 20 | 27 | 74.1% | |
| NM84 | 2017 | 24 | 36 | 66.7% | |
| NM84 | 2018 | 23 | 38 | 60.5% | |
| NM84 | 2019 | 19 | 29 | 65.5% | |
| NM84 | 2020 | 31 | 41 | 75.6% | |
| NM84 | 2022 | 32 | 45 | 71.1% | |
| NM84 | 2023 | 39 | 51 | 76.5% |
